Sanjay Khosla - Zoetis Independent Director
| ZTS Stock | USD 178.54 0.29 0.16% |
Director
Mr. Sanjay Khosla is Independent Director of the Company. Mr. Khosla brings more than 35 years of international business experience from his career with food, beverage and consumer product leaders such as Mondelez, Kraft and Unilever, where he managed various business units, particularly in developing markets. As President, Kraft Foods, Developing Markets from 2007 to 2013, Mr. Khosla transformed the 5 billion business into a 16 billion business, while significantly improving profitability. He also has animal health experience from his threeyear tenure from 2004 to 2007 as Managing Director of Fonterra Brands and Food Service, a multinational dairy cooperative based in New Zealand. Mr. Khosla formerly served on the board of Iconix Brand Group, Inc., a company that licenses and markets a portfolio of consumer brands, from 2016 to 2018. From 2008 until 2015, he served on the board of Best Buy, Inc., a specialty retailer of consumer electronics, personal computers, entertainment software and appliances, and from 2002 to 2017, he served on the board of NIIT, Ltd., a company involved in technologyrelated educational services. Mr. Khosla holds a bachelors degree in electrical engineering from the Indian Institute of Technology in New Delhi. Mr. Khosla also completed the Advance Management Program at Harvard Business School. Mr. Khosla is currently a senior fellow and adjunct professor at the Kellogg School of Management, Northwestern University and a Senior Advisor for the Boston Consulting Group. Mr. Khosla is also CEO of Bunnik LLC, a management consulting firm. Mr. Khoslas international business and management experience, along with his public company board experience, make him a valuable member of our Board. since 2013.
| Age | 68 |
| Tenure | 11 years |
| Address | 10 Sylvan Way, Parsippany, NJ, United States, 07054 |
| Phone | 973 822 7000 |
| Web | https://www.zoetis.com |
Zoetis Management Efficiency
The company has Return on Asset of 0.1399 % which means that on every $100 spent on assets, it made $0.1399 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.5005 %, implying that it generated $0.5005 on every 100 dollars invested. Zoetis' management efficiency ratios could be used to measure how well Zoetis manages its routine affairs as well as how well it operates its assets and liabilities. Return On Assets is likely to gain to 0.17 in 2024, whereas Return On Tangible Assets are likely to drop 0.12 in 2024. At this time, Zoetis' Intangible Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 336.9 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 5.6 B in 2024.Management Performance
Zoetis Inc Leadership Team
Elected by the shareholders, the Zoetis' board of directors comprises two types of representatives: Zoetis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zoetis. The board's role is to monitor Zoetis' management team and ensure that shareholders' interests are well served. Zoetis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zoetis' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Roman Trawicki, Executive Vice President and Presidentident of Global Manufacturing and Supply | ||
| Steven Frank, Vice Relations | ||
| Kristin Peck, Chief Executive Officer, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy, Director | ||
| Wafaa Mamilli, Executive Vice President and Chief Information and Digital Officer | ||
| William Steere, Independent Director | ||
| Roxanne Lagano, Chief Human Resource Officer, Executive Vice President and Global Operations | ||
| Linda Rhodes, Independent Director | ||
| Timothy Bettington, Executive Vice President and President U.S. Operations | ||
| Ester Banque, Executive Operations | ||
| Frank DAmelio, Independent Director | ||
| Robert Scully, Independent Director | ||
| Sherry Pudloski, Executive Vice President - Corporate Affairs and Communications | ||
| Sanjay Khosla, Independent Director | ||
| William Price, VP Officer | ||
| Jamie Brannan, Executive Diagnostics | ||
| Catherine Knupp, Executive Vice President, President - Research and Development | ||
| Jeannette Astorga, Executive Officer | ||
| Michael McCallister, Non-Executive Independent Chairman of the Board | ||
| Paul Bisaro, Independent Director | ||
| Antoinette Leatherberry, Independent Director | ||
| Nick Ashton, Executive Supply | ||
| Willie Reed, Independent Director | ||
| William Dorsey, Vice Diagnostics | ||
| Rimma Driscoll, Commercial Strategy | ||
| Glenn David, Chief Financial Officer, Executive Vice President | ||
| Wetteny Joseph, Chief Financial Officer, Executive Vice President, Head of Business Development | ||
| Robert Kelly, Executive Vice President and President International Operations | ||
| J McFarland, Executive Vice President and Chief Medical Officer | ||
| Robert Polzer, Executive Vice President and Presidentident of Research and Development | ||
| Gregory Norden, Independent Director | ||
| Louise Parent, Independent Director | ||
| Heidi Chen, Executive Vice President General Counsel, Corporate Secretary | ||
| Abhay Nayak, Executive Vice President Head of Strategy and Accelerated Growth Businesses | ||
| Juan Alaix, Chief Executive Officer, Director |
Zoetis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zoetis a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.5 | ||||
| Return On Asset | 0.14 | ||||
| Profit Margin | 0.27 % | ||||
| Operating Margin | 0.37 % | ||||
| Current Valuation | 86.42 B | ||||
| Shares Outstanding | 456.3 M | ||||
| Shares Owned By Insiders | 0.24 % | ||||
| Shares Owned By Institutions | 95.74 % | ||||
| Number Of Shares Shorted | 6.03 M | ||||
| Price To Earning | 43.89 X |
Pair Trading with Zoetis
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Zoetis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zoetis will appreciate offsetting losses from the drop in the long position's value.Moving against Zoetis Stock
| 0.42 | ANVS | Annovis Bio Earnings Call Today | PairCorr |
| 0.36 | PRGO | Perrigo Company Buyout Trend | PairCorr |
The ability to find closely correlated positions to Zoetis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Zoetis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Zoetis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Zoetis Inc to buy it.
The correlation of Zoetis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Zoetis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Zoetis Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Zoetis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Zoetis Stock Analysis
When running Zoetis' price analysis, check to measure Zoetis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zoetis is operating at the current time. Most of Zoetis' value examination focuses on studying past and present price action to predict the probability of Zoetis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zoetis' price. Additionally, you may evaluate how the addition of Zoetis to your portfolios can decrease your overall portfolio volatility.